Stutsky explains why shifting therapy perceptions had more pharmacist touchpoints and longer time on therapy among patients with ATTR-CM.
|Articles|April 5, 2011
ACC 2011 Interivew on Atrial Fibrillation Cost in Rate vs Rythm Control
Dr. Poulin discusses his poster which is a cost analysis of 300 patients from Quebec, Canada, in an atrial fibrillation and congestive heart failure trial.
Advertisement
Advertisement
Related to this article
MA-to-MA switching among dually eligible beneficiaries rose sharply from 2016 to 2022, AJMC study author Grace Mackleby, PhD, found.
Advertisement
Advertisement
Trending on AJMC
1
Predoc and Nebraska Cancer Specialists: Not Letting the Fax Be the Fumble
2
Postvaccine Hepatitis Reports More Often Serious in Children vs Adults
3
CMS Moves TIC Reporting to Quarterly, Sets Drug File Timeline
4
Will Cancer Care Come Home by 2030? PCOC Panelists Differ on Strategy
5